期刊文献+

早期帕金森病的中西医结合神经保护诊治思路 被引量:2

Diagnosis and Treatment Strategy for Neuroprotection with Combined TCM and Western Medicine in the Early Stage of Parkinson's Disease
下载PDF
导出
摘要 神经保护是指一个过程,即某种治疗能有益地影响帕金森病(PD)的病理生理学基础,同"多巴胺拟似剂等对症疗法"相比,它可能推迟发病或延缓病情的发展。介绍存在亚临床或临床前期PD的证据,并对PD的早期诊断及中医、西医神经保护的现状进行了述评,提出早期PD中西医结合神经保护的防治策略,包括加强预防,增加循证医学证据,加强实验研究,利用新技术动态观察与PD有关的生物指标等,强调指出开发"多重靶标治疗神经退行性疾病的多功能药物"的中药复方设想。 Neuroprotecfion is a process in which a treatment beneficially affects the underlying pathophysiology of Parkinson's disease (PD). Compared with dopamine agonists heteropathy, it could delay the onset or postpone the deveopment of disease. Evidences for the exist of sub - clinical or prc - clinical PD are introduced. The early diagnosis for PD, and the current status for neuroprotection with TCM and western medicine are stated. The diagnosis and treatment strategy for neuroproteetion with combined TCM and westem medicine in the early stage of PD arc put forward. These strategies inelude the enhancement of prophylaxis, the increase of evidence - based medicine proofs, the reinforce of experimental research and the dynamic observation of PD related biological indexes with new techniques. Emphasis is put on the presumption of developing eomplex prescription of traditional Chinese medicine that could work as multifunetion drugs with multi - targets for the treatment of neuro - degenerative disease.
出处 《中华中医药学刊》 CAS 2008年第1期196-199,共4页 Chinese Archives of Traditional Chinese Medicine
关键词 帕金森病 早期诊断 神经保护 诊治策略 中西医结合 Parkinson's disease early diagnosis neuroprotection diagnosis and treatment strategy combination of TCM and westem medicine
  • 相关文献

参考文献15

  • 1[1]Piccini P,Morrish PK,Turjanski N,et al.Dopaminergic function in familial Parkinson's disease:a clinical and 18F-dopa positron emission tomography study[J].Ann Neurol,1997,41:222-229.
  • 2[2]Laihinen A,Ruottinen H,Rinne JO,et al.Risk for Parkinson's disease:twin studies for the detection of asymptomatic subjects using[18F]6-fluorodopa PET[J].J Neurol,2000,247:110-113.
  • 3[3]Suchowersky O,Reich S,Perlmutter J,et al.Practice Parameter:diagnosis and prognosis of new onset Parkinson disease (an evidence-based review):report of the Quality Standards Subcommittee of the American Academy of Neurology[J].Neurology,2006,66:968-975.
  • 4[4]Tolosa E,Wenning G,Poewe W.The diagnosis of Parkinson's disease[J].Lancet Neurol,2006,5:75-86.
  • 5[5]Developed by National Collaborating Centre for Chronic Conditions Royal College of Physicians.Parkinson's disease:full guideline DRAFT[S].2006.
  • 6[6]Ravina BM,Fagan SC,Hart RG,et al.Neuroprotective agents for clinical trials in Parkinson's disease:a systematic assessment[J].Neurology,2003,60:1234-1240.
  • 7杨春艳,邹坤.天然药物神经保护作用的研究进展[J].中草药,2005,36(3):461-464. 被引量:2
  • 8王卫霞,王巍,陈可冀.人参皂苷对动物脑神经保护作用及其机理研究进展[J].中国中西医结合杂志,2005,25(1):89-93. 被引量:30
  • 9孙晓芳,王巍,王丹巧,杜贵友.天麻及其制剂神经保护机制的研究进展[J].中国中药杂志,2004,29(4):292-295. 被引量:42
  • 10方向,鲍远程.中医药治疗帕金森病作用机制研究概述[J].安徽中医学院学报,2004,23(3):57-59. 被引量:4

二级参考文献98

共引文献120

同被引文献23

  • 1Martinez - Martin P, Schapira A14, Stocchi F, et al. Prevalence of non- motor symptoms in Parkinson's disease in an international setting; study using nonmotor symptoms questionnaire in 545 patients [ J ~. Mov Disord ,2007,22 ( 11 ) : 1623 - I629.
  • 2Chaudhuri KR, Schapira AH. Non - motor symptoms of Parkinson's disease : dopaminergic pathophysiology and treatment[ J ~. Lancet Neu- rol,2009,8(5 ) :464 -474.
  • 3Kurmner A, Teixeira AL. Neuropsychiatry of Parkinson's disease [ J 1. Arq Neuropsiquiatr,2009,67 ( 3 - B ) :930 - 939.
  • 4Oertel WH, Berardelli A, Bloem BR,et al. European Handbook of neu- rological[ M ]. Management Blackwell publishing Ltd, 2011 : 237 - 267.
  • 5Abbott RD, Petrovitch H, White LR, et al. Frequency of bowelmove- ments and future risk of Parkinson's disease[ J]. Neurology,2001,57: 456 - 462.
  • 6Hirayama M. Sweating dysfunctions in Parkinson's disease [ J ]. J Neu- rol,2006,253 Suppl 7:42 -47.
  • 7Swinn L, Schrag A, Viswanathm~ R. et al. Sweating dysfunction in Par- kinson's disease [ J 1. Mov Disord ,2003,18 : 1459 - 1463.
  • 8Pursiainen V, Haapaniemi TH. Korpelainen JT. et al. Sweating in Par- kinsonian patients with wearing -off[ J ]. Mov Disord ,2007,22:828 - 832.
  • 9Chaudhuri KR. Nocturnal symptom complex in PD and its manage- ment [ J ]. Neurology,2003,61 ( Supp 3 ) : S17 - $23.
  • 10Poewe W, Hogl BE. Parkinson's disease and sleep [ J]. CuxT Opin Neurol,2000,13:423 - 426.

引证文献2

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部